Molecular Docking Study Characterization of Rare Flavonoids at the Nac-Binding Site of the First Bromodomain of BRD4 (BRD4 BD1)
Author(s) -
Karthik Dhananjayan
Publication year - 2015
Publication title -
journal of cancer research
Language(s) - English
Resource type - Journals
eISSN - 2356-7201
pISSN - 2314-6915
DOI - 10.1155/2015/762716
Subject(s) - bromodomain , brd4 , chemistry , binding site , docking (animal) , acetylation , naringenin , transcription factor , in silico , biochemistry , epigenetics , microbiology and biotechnology , biology , gene , flavonoid , medicine , nursing , antioxidant
ε-N-Acetylation of lysine residues (Kac) is one of the most frequently occurring posttranslational modifications (PTMs) which control gene transcription and a vast array of diverse cellular functions. Bromodomains are epigenetic regulators involved in posttranslational modification. In silico docking studies were carried out to evaluate the binding potential of selected rare flavonoids on to Nac binding site of BD1 domain of BRD4 BET family proteins. Rare flavonoids like 3-O-acetylpinobanksin, naringenin triacetate, and kaempferol tetraacetate were found to occupy the WPF shelf and at the same time they exhibited a better binding affinity with multiple crystal structures of first bromodomain BRD4 (BRD4 BD1) when compared with the known inhibitors
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom